- Total Pro Portfolios with MHS:
- Fidelity Select Medical Delivery FSHCX
- Glenview Capital Management
- Accipiter Capital Management
- Argus Management
- BlackRock Large Cap Growth - MDLHX
- show more
- Total Do-It-Yourself Portfolios with MHS:
- Rav Bruce's Top Holdings
- jpf
- legend of Zeta
- MrCoates Portfolio 1
- David M. Clark Portfolio 1
- GTA long term Portfolio 1
- Richard Ullmax Portfolio 1
- 12nov07 Jena
- LM Taylor Portfolio 1
- tdegilio Portfolio 1
- Longish
- my own mut fund
- Rod Clark Portfolio 1
- Duncan (17.1.2007)
- David Fly Portfolio 1
- Barron's: Momentum Stocks from Turner investments
- pj
- Wedding Fund
- Rick1960
- Rimp's Stockpicks
- lrbs3
- Linny Portfolio 1
- jrm Portfolio 1
- Brett Manning Portfolio 1
- DGB Longs
- NorthsideDINK - 11/07
- hogwash58 Portfolio 1
- flyholm Portfolio 1
- A few stocks
- cephas Portfolio 1
- herschthal Portfolio 1
- ronmarcusps Portfolio 1
- Geck68 Portfolio 1
- EPLISNER PERSONAL
- chucknmmi Portfolio 1
- breadstein Portfolio 1
- jefframs Portfolio 1
- brighto Portfolio 1
- Karen Grippo Portfolio 1
- chrismco Portfolio 1
- rafita123 Portfolio 1
- jack2
- dbyer52 Portfolio 1
- Bjosie280 Portfolio 1
- Portfolio - Actual
- DDFASTD#2 CNBC
- ybormel Portfolio 1
- scottie1101
- currancy
- MR.HAROLD Portfolio 1
- einvest1
- show more
- 535
- Whatever Portfolio 1
- jpf prod
- Charles211 Portfolio 1
- top dog
- James Wright
- Jason Cho Portfolio 1
- Karl's SD IRA
- Jnh069 Portfolio 1
- chad thompson-smith Portfolio 1
- Eddie Kelly Portfolio 1
- CD1
- frank masi Portfolio 1
- biggaijin Portfolio 1
- momoney101
- HopeforQuality
- sailor1 Portfolio
- Joecap
- Stocks 1
- secondary
- D-1
- Chet 3
- kambert Portfolio 1
- di 22 Portfolio 1
- Buy and Sell
- Richie Rich MO's
- FIRST CHOICE
- bapapo Portfolio 1
- mommymrc Portfolio 1
- Barron's: Biotech Clones
- sharrison99
- pratice one
- gaisford Portfolio 1
- mshah Portfolio 1
- greghansen Current Portfolio
- GL IRA
- lgunby Portfolio 1
- mrvain Portfolio 1
- beartrends Portfolio 1
- DOCTORSL
- NewPicks
- amrad6
- jepstockpickr Portfolio 1
- reed0380 Portfolio 1
- George Stocks of Interest
- James Stevens Portfolio 1
- jbaumohl Portfolio 1
- btPortfolio-02
- LEF Health
- DanIraSC
- DryGuy
- News For Selected Stock
- Related stories on theStreet.com
- videos related to etf's
- Cramer: Obama's Win Gi...
- show more
- 11/05/08
- blogs related to etf's
- No blogs found
Why I Love This Stock |
|
By:barrons3 |
Date:11 22 08 |
One that Douglas Cliggott's been adding in the downdraft is the country's biggest pharmacy benefits manager, Medco Health Solutions (MHS), down a third from its highs to 37.32. Medco stock dropped roughly as much as the broad market did from mid-September to the end of October. That suggests indiscriminate selling of Medco, which has been beaten down to a relatively low P/E, almost 14 times forward earnings, lower than its growth rate. It's rare to get Medco at a discount to its growth, says Cliggott. For the first nine months, Medco sales rose 17% to $38.3 billion and profits 25% to $829 million, or $1.74 a share. Medco expects 2008 earnings of $2.30-$2.33 a share, up 20% from 2007, and $2.67-$2.77 next year, up 15%. And it plans to buy back some $3 billion of shares. Tough economic times could play to Medco's strength. Fast-rising heath-care costs are one of Corporate America's biggest problems, so the cost benefits of mail-order drug fulfillment and generics, for example, have wide appeal to companies and consumers. Medco attributed part of its 38% third-quarter profit jump to a rise in clients and their desire to cut drug-benefit costs. |
|
Not yet rated
Rate now:
|
|
By:barrons3 |
Date:11 08 08 |
But there also could be some winners in health care. Cliggott thinks generic drug maker Teva Pharmaceutical Industries (TEVA) could benefit from any assault on drug pricing. And the CEO of managed-care company Humana (HUM), Michael McAllister, has said that his company can benefit by bringing technology systems and other efficiencies to the insurance market. Medco Health Solutions (MHS) and Express Scripts (ESRX) also could benefit, as each offers pharmacy-benefits services. |
|
Not yet rated
Rate now:
|
|
Date:09 21 08 |
|
Entered long on 9/8/08 at 48.75 |
|
Not yet rated
Rate now:
|
|
By:sarah z |
Date:09 16 08 |
From a recent Mad Money show: "This is one of the great healthcare stocks. I think they can beat the competition; they are really well run." |
|
Not yet rated
Rate now:
|
|
By:barrons2 |
Date:07 02 08 |
You can see MedcoHealth (MHS), Cardinal Health (CAH) and Quest Diagnostics (DGX) rallying, another cohort that's struggling to put in a recession bottom. |
|
Not yet rated
Rate now:
|
|
By:itsracerx |
Date:06 07 08 |
pharmacy support |
|
Not yet rated
Rate now:
|
|
By:barrons2 |
Date:05 22 08 |
Finally, Cramer revisited Medco Health (MHS), a stock which is up just 0.7% since the November mention. Cramer said that while Medco makes its money whether or not the economy does well, it has more competition that he originally thought and perhaps the traditional defensive stock wasn't right for this portfolio. He told viewers "if it rallies, I'd sell it." |
|
Not yet rated
Rate now:
|
|
By:barrons2 |
Date:04 24 08 |
In fact, the only real defenser that is higher is Medco (MHS), and that's because UnitedHealth (UNH) blew it again. Oops, hate to write this, but UNH really is a bunch of clowns. |
|
Not yet rated
Rate now:
|
|
By:Pro |
Date:11 30 -1 |
Medco Health (MHS) was upgraded from Hold to Buy, Citigroup said. $57 price target. Company renewed its contract with UNH, a major customer, through 2012. |
|
Not yet rated
Rate now:
|
|
By:Pro |
Date:11 30 -1 |
MedcoHealth Solutions (MHS) was upgraded at Credit Suisse. Upgraded to Outperform from Neutral. 2008 EPS estimates raised to $2.33 from $2.30. Maintains $58 price target. |
|
Not yet rated
Rate now:
|
|



